Low-dose Intravenous Magnesium Sulfate: Efficacy and Safety in Eclamptic Indian Women

JOURNAL TITLE: Journal of South Asian Federation of Obstetrics and Gynaecology

Author
1. Mohita Agarwal
2. Saroj Singh
3. Almas Ara
ISSN
0974-8938
DOI
10.5005/jp-journals-10006-1661
Volume
11
Issue
2
Publishing Year
2019
Pages
5
Author Affiliations
    1. Department of Obstetrics and Gynecology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India
    1. SN Medical College, Agra, Uttar Pradesh, India
    2. S.N. Medical College, Agra
    3. Agra, Uttar Pradesh, India
    4. Agra
    1. Department of Obstetrics and Gynaecology, SN Medical College, Agra, Uttar Pradesh, India
  • Article keywords
    Eclampsia, Low-dose magnesium sulfate, Pritchard\'s regimen

    Abstract

    Objective: The aim of our study was to evaluate the efficacy and safety of low dose intravenous magnesium sulfate against the conventional Pritchard's regimen in cases of eclampsia. Materials and methods: A total of 60 eclamptic cases attending the labor room were randomly allocated to receive low dose intravenous magnesium sulfate, i.e., 4 g intravenous bolus dose followed by a 0.8 g per hour maintenance dose to be continued up to 24 hours after delivery or the last fit, whichever is later, or conventional Pritchard's regimen. The two groups were compared for efficacy and safety. Results: Low-dose regimen was found to have a statistically significant lower incidence of side-effects and complications. Failure of therapy was seen in more number of cases with low dose because of the lower serum magnesium levels. Conclusion: Low-dose regimen is a good option for lean Indian women especially at the peripheral centers where intensive serum magnesium level monitoring is not practically feasible because of reduced risk of toxicity.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved